At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism
In Brief
A Phase 2 clinical trial evaluating Intranasal Oxytocin and Placebo for Autism Spectrum Disorder. Completed, enrolled 60 participants across 2 sites in 2 countries.
Detailed Summary
We are studying an investigational drug called intranasal oxytocin (Syntocinon®). Syntocinon® has been approved by the U.S. Food and Drug Administration for use in helping women breastfeed, but it has not been approved for use in children with ASD. However, there is previous research conducted that has indicated that after administration of oxytocin, adults with ASD demonstrated improvements in social cognition, and reduced repetitive behaviours and anxiety. There is also early research to suggest that children may also benefit in these areas. The purpose of this study is to test if oxytocin works to help children and adolescents with ASD.